Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3

Completed · Phase 1

Conditions studied: Opioid-Related Disorders, Substance-Related Disorders

In brief

The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.

Key facts

Study ID

NCT00000354

Run by

National Institute on Drug Abuse (NIDA)

People needed

0

Starts

1996-07-01

Expected to finish

1997-12-01

Last updated by the study team

2017-01-12

Who can join

Age: 21 and older, up to 59. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.